Full-Time

Business Development Manager

Updated on 7/12/2026

PerkinElmer

PerkinElmer

5,001-10,000 employees

Analytical instruments and software for health

Compensation Overview

$150k - $175k/yr

Burlington, MA, USA

In Person

On-site in Woburn, Massachusetts; willing to travel 20-40%.

Category
Business & Strategy (1)
Required Skills
Sales

People at PerkinElmer

People at PerkinElmer who can refer or advise you

Requirements
  • Bachelor’s degree in Life Sciences, Business, or related field.
  • 5+ years of business development or sales experience in medical devices, diagnostics, CROs, or life sciences tools.
  • Demonstrated success selling into healthcare systems, biopharma, or clinical research organizations.
  • Experience with consultative and solution-based selling models.
  • Strong understanding of clinical trial workflows or diagnostic laboratory operations.
  • Ability to travel as required (20–40%)
Responsibilities
  • Strategic Business Development: Identify and develop new revenue opportunities in decentralized clinical trials, telemedicine, population health, and remote diagnostics.
  • Build and execute territory and account growth plans.
  • Establish partnerships with CROs, pharma sponsors, diagnostic laboratories, and digital health companies.
  • Develop channel strategies including distributors and strategic OEM collaborations.
  • Market Expansion & Revenue Growth: Drive sales pipeline from prospecting through contract negotiation and close.
  • Achieve quarterly and annual revenue targets.
  • Position the device as a scalable solution for remote patient sample collection.
  • Identify reimbursement and health economics drivers to support adoption.
  • Stakeholder Engagement: Engage clinical operations leaders, lab directors, R&D heads, procurement, and executive leadership.
  • Lead product demonstrations and value-based presentations.
  • Translate technical features into clinical and operational value.
  • Industry Representation: Represent the company at conferences, industry events, and customer meetings.
  • Develop thought leadership relationships in decentralized healthcare.
  • Provide pre- and post-sales technical and scientific presentations, to small groups and large audiences, on the use of above technology in life science and clinical research.
  • Cross-Functional Collaboration: Work closely with regulatory, clinical, marketing, and product teams.
  • Provide market intelligence to inform product roadmap and positioning.
  • Support pilot programs and early adopter deployments.
  • Create and maintain support information in the company enterprise database.
  • Develop and implement training plans and courses for internal and external customers.
  • Planning and overseeing new marketing initiatives and participating in new product development projects as a representative of the commercial and technical support teams; Assist in the creation and review of technical materials (manuals, application notes, presentations).
  • Mapping and communicating potential clients to establish rapport and arrange meetings, researching organizations and individuals to find new opportunities.
  • Increasing the value of current customers while attracting new ones.
  • Attending conferences, meetings, and industry events.
Desired Qualifications
  • Experience in remote patient monitoring, microsampling, or decentralized trials.
  • Knowledge of regulatory pathways (FDA, CE) for medical devices.
  • Familiarity with reimbursement strategy and health economics.
  • MBA or advanced life sciences degree.

PerkinElmer provides analytical instruments, software, and services for the life sciences, diagnostics, and environmental health markets. Customers use these tools to collect and analyze data through a combination of hardware, consumable supplies, and software licensing. Unlike many competitors, the company integrates a global service network with a focus on sustainability by designing products that reduce waste and energy consumption. Its goal is to improve human and environmental health by helping laboratories and industrial companies achieve more efficient and accurate scientific results.

Company Size

5,001-10,000

Company Stage

Acquired

Total Funding

$2.5B

Headquarters

Shelton, Connecticut

Founded

1937

People at PerkinElmer

People at PerkinElmer who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • New CEO Michael Stubblefield drives innovation and customer value post-New Mountain Capital's $2.45B 2023 acquisition.
  • Project Farma acquisition expands OneSource Professional Services, adding $15–25M revenue to its life sciences portfolio.
  • Covalent collaboration targets semiconductor and battery sectors where ultra-trace impurity detection is critical for quality control.

What critics are saying

  • Shelton factory closure and 68 layoffs in 0–6 months disrupt US manufacturing capacity and erode local continuity.
  • Covalent revenue concentration in cyclical semiconductor/battery sectors faces high risk from 2024–2025 chip slowdown demand drops.
  • Project Farma integration risks $8–12M cost overruns and bio-pharma contract lags through Q1 2026, threatening high impact.

What makes PerkinElmer unique

  • PerkinElmer combines 90 years of innovation with ICP-MS/MS and LC-MS/MS for ultra-trace semiconductor and battery failure analysis.
  • Its Avio 3000 ICP-OES uses patented HeliPlate plasma technology to cut argon consumption by 50% while maintaining high throughput.
  • The company integrates sample homogenization in LactoScope 500 to stabilize high-fat dairy measurements and reduce product giveaway.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Enviro-Tech Services
May 29th, 2026
A new benchmark for high throughput cost efficient ICP OES.

A new benchmark for high throughput cost efficient ICP OES. 29 May, 2026 PerkinElmer AES (UK) Limited Building on decades of ICP-OES innovation and market leadership, the Avio(R) 3000 expands PerkinElmer's portfolio, enabling high-speed analysis with outstanding stability and detection limits, low operating costs, and simplified workflows that deliver accurate, defensible data. PerkinElmer recently announced the launch of the Avio(R) 3000 inductively coupled plasma optical emission spectrometer, their top-tier true simultaneous ICP-OES. Engineered to support laboratories operating under constant throughput and cost pressures, the Avio 3000 delivers rapid ICP-OES analysis alongside data consistency required for regulatory-driven environments. Optimised for efficiency and reliability, the system reduces consumables, energy use, and operational complexity to deliver measurable cost savings. The combination of high performance and low operating costs in the Avio 3000 ICP-OES is made possible by the seamless integration of third-generation proprietary technologies with field-proven ones, allowing laboratories to achieve high analytical performance while maintaining efficient, cost-effective operation. Third-generation proprietary technologies include: a patented detector designed exclusively for ICP-OES, delivering improved signal-to-background ratio, precision, and speed; a cutting-edge optical system that enhances data quality while simplifying operation; patented HeliPlate(TM) plasma technology that consumes up to 50% less argon than traditional helical coil systems while improving plasma robustness; chiller-free operation further contributes to savings in electricity, heat, noise, and maintenance, reduces the carbon footprint, and occupies less laboratory space. The Avio 3000 builds on a strong tradition of reliable, low-maintenance instrumentation, providing a high-performance true simultaneous ICP-OES system with reduced on-going operating costs.

The Associated Press
Feb 5th, 2026
Perten opens Process NIR Center of Excellence in Stockholm for food manufacturers

Perten, a PerkinElmer company specialising in food quality control solutions, has opened a Process NIR Center of Excellence at its Stockholm headquarters. The facility is designed to help food manufacturers adopt near-infrared technology for real-time process monitoring and quality control. The centre offers live demonstrations of Perten's benchtop, in-line and on-line NIR analysers using real samples, helping customers transition from traditional laboratory testing to continuous measurement. The facility supports collaborative development across various food sectors, including grains, cereals, dairy processing, snack foods and edible oils. Managing Director Paul Morrison said the centre enables customers to achieve tighter process control, reduced waste and improved margins. The facility complements Perten's global network of technical support and maintains an extensive library of validated calibrations for faster deployment.

New Haven Register
Sep 24th, 2025
PerkinElmer to close Shelton factory next year and lay off 68

Analytical equipment maker PerkinElmer is closing its Bridgeport Avenue factory in Shelton and laying off 68 people in the process, company officials informed representatives of the Connecticut Department of Labor on Tuesday.

Business Wire
Mar 12th, 2025
PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

PerkinElmer, a global leader in analytical solutions and specialized services for (bio)pharma, applied and food markets, today announced the acquisiti

Business Wire
Mar 11th, 2025
PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

PerkinElmer acquires Project Farma, expanding its OneSource professional services offering for the life sciences industry.